United States
US 12,697,351 B2
Method of treating conditions, reducing an inflammatory response, or improving organ function in a subject having a corona virus infection by administering an inhibitor of C5a activity
US 12,697,351 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-04. Applicant: InflaRx GmbH. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- InflaRx GmbH
- Inventors
- Niels C. RIEDEMANN; Renfeng GUO
- Publication date
- 2026-08-04
- Filing date
- 2022-09-26
- Document type
- B2 Granted patent
- Also written as
- US 12,697,351 B2 · US12697351 · 12697351
Abstract
The present invention relates to an inhibitor of C5a activity medical condition caused by or associated with infection with a corona virus. The invention also relates to the use of an inhibitor of C5a activity in the reduction of an inflammatory response in a subject suffering from a corona virus infection. The invention further relates to an inhibitor of C5a activity for use in the improvement of organ function, in particular lung function and/or hepatic function, in a subject suffering from a corona virus infection.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free